In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: A review of the literature

Annals of the New York Academy of Sciences

Volumn 1344, Issue 1, 2015, Pages 50-65

  Lener, Marc S ^a   Iosifescu, Dan V ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Functional; Major depressive disorder; Morphometry; Neuroimaging; Resting state; SPECT; Structural; Treatment resistant depression; Voxel based; White matter

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; BIOLOGICAL MARKER;

ARTICLE; BRAIN SIZE; DIFFUSION TENSOR IMAGING; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; MAJOR DEPRESSION; META ANALYSIS (TOPIC); NEUROIMAGING; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; WHITE MATTER; ANIMAL; BRAIN; FUNCTIONAL NEUROIMAGING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; RADIOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; DEPRESSIVE DISORDER, MAJOR; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84928301777     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12759     Document Type: Article

References (177)

1. Mueller, T.I., A.C. Leon, M.B. Keller, et al. 1999. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am. J. Psychiatry 156: 1000-1006.
2. Rush, A.J., M.H. Trivedi, S.R. Wisniewski, et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163: 1905-1917.
3. Kessler, R.C., P. Berglund, O. Demler, et al. 2003. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.
4. Fava, M. & K.G. Davidson . Deinition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 19: 179-200.
5. Fava, M. 2003. Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 53: 649-659.
6. Fava, M. & A.J. Rush . 2006. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother. Psychosom. 75: 139-153.
7. World Health Organization. 2006. World Health Report 2006. Statistical annex. http://www.who.int/whr/2006/en/
8. Mrazek, D.A., J.C. Hornberger, C.A. Altar & I. Degtiar . 2014. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. Psychiatr. Serv 65: 977-987.
9. Cuthbert, B. 2010. New, rapidly-acting treatments for treatment-resistant depression (RAPID). National Advisory Mental Health Council (NAMHC) Concept Clearance. National Institute of Mental Health. May 14, 2010.
10. Niciu, M.J., D.C. Mathews, A.C. Nugent, et al. 2014. Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants. Depress Anxiety 31: 297-307.
11. McGrath, C.L., M.E. Kelley, P.E. Holtzheimer, et al. 2013. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatr. 70: 821-829.
12. Insel, T., B. Cuthbert, M. Garvey, et al. 2010. Resarch Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167: 748-751.
13. Lorenzetti, V., N.B. Allen, A. Fornito & M. Yücel . 2009. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J. Affect Disord. 117: 1-17.
14. Kempton, M.J., Z. Salvador, M.R. Munafò, et al. 2011. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch. Gen. Psychiatry 68: 675-690.
15. Bora, E., B.J. Harrison, C.G. Davey, et al. 2012. Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. Psychol. Med. 42: 671-681.
16. Du, M.Y., Q.Z. Wu, Q. Yue, et al. 2012. Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 36: 11-16.
17. Sacher, J., J. Neumann, T. Fünfstück, et al. 2012. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J. Affect Disord. 140: 142-148.
18. Lai, C.H. 2013. Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies. Psychiatry Res. 211: 37-46.
19. Drevets, W.C., J.L. Price & M.L. Furey . 2008. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 213: 93-118.
20. Rajkowska, G. et al. 1999. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45: 1085-1098.
21. Rajkowska, G. 2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48: 766-777.
22. Ongür, D., W.C. Drevets & J.L. Price . 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Nat. Acad. Sci. U.S.A. 95: 13290-13295.
23. Duman, R.S. & G.K. Aghajanian . 2012. Synaptic dysfunction in depression: potential therapeutic targets. Science 338: 68-72.
24. Willard, S.L., D.R. Riddle, M.E. Forbes & C.A. Shively . 2013. Cell number and neuropil alterations in subregions of the anterior hippocampus in a female monkey model of depression. Biol. Psychiatry 74: 890-897.
25. Amico, F., E. Meisenzahl, N. Koutsouleris, et al. 2011. Structural MRI correlates for vulnerability and resilience to major depressive disorder. J. Psychiatry Neurosci. 36: 15-22.
26. Bremner, J.D., M. Narayan, E.R. Anderson, et al. 2000. Hippocampal volume reduction in major depression. Am. J. Psychiatry 157: 115-118.
27. McKinnon, M.C., K. Yucel, A. Nazarov & G.M. MacQueen . 2009. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J. Psychiatry Neurosci. 34: 41-54.
28. Sheline, Y.I., M.H. Gado & H.C. Kraemer . 2003. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160: 1516-1518.
29. Frodl, T., E.M. Meisenzahl, T. Zetzsche, et al. 2004. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J. Clin. Psychiatry 65: 492-499.
30. Frodl, T., M. Jäger, I. Smajstrlova, et al. 2008. Effect of hippocampal and amygdala volumes on 28. Clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J. Psychiatry Neurosci. 33: 423-430.
31. Malykhin, N.V., R. Carter, P. Seres & N.J. Coupland . 2010. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J. Psychiatry Neurosci. 35: 337-343.
32. Huang, Y., N.J. Coupland, R.M. Lebel, et al. 2013. Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study. Biol. Psychiatry 74: 62-68.
33. Nordanskog, P., U. Dahlstrand, M.R. Larsson, et al. 2010. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT. 26: 62-67.
34. Whittle, S., R. Lichter, M. Dennison, et al. 2014. Structural brain development and depression onset during adolescence: a prospective longitudinal study. Am. J. Psychiatry 171: 564-571.
35. Yucel, K., M. McKinnon, R. Chahal, et al. 2009. Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder. Psychiatry Res. 173: 71-76.
36. Takahashi, T., M. Yücel, V. Lorenzetti, et al. 2010. Volumetric MRI study of the insular cortex in individuals with current and past major depression. J. Affect. Disord. 121: 231-238.
37. Salvadore, G., A.C. Nugent, H. Lemaitre, et al. 2011. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage 54: 2643-2651.
38. Liu, C.H., B. Jing, X. Ma, et al. 2014. Voxel-based morphometry study of the insular cortex in female patients with current and remitted depression. Neuroscience 262: 190-199.
39. Chen, C.H., K. Ridler, J. Suckling, et al. 2007. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol. Psychiatry 62: 407-414.
40. Soriano-Mas, C., R. Hernández-Ribas, J. Pujol, et al. 2011. Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol. Psychiatry 69: 318-325.
41. Sämann, P.G., D. Höhn, N. Chechko, et al. 2013. Prediction of antidepressant treatment response from gray matter volume across diagnostic categories. Eur. Neuropsychopharmacol 23: 1503-1515.
42. MacQueen, G.M., K. Yucel, V.H. Taylor, et al. 2008. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol. Psychiatry 64: 880-883.
43. Phillips, J.L., L.A. Batten, F. Aldosary, et al. 2012. Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J. Clin. Psychiatry 73: 625-631.
44. Li, C.T., C.P. Lin, K.H. Chou, et al. 2010. Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage 50: 347-356.
45. Fu, C.H., H. Steiner & S.G. Costafreda . 2013. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol. Dis. 52: 75-83.
46. Gong, Q., Q. Wu, C. Scarpazza, et al. 2011. Prognostic prediction of therapeutic response in depression using high-field MR imaging. Neuroimage 55: 1497-1503.
47. Krishnan, K.R., J.C. Hays & D.G. Blazer . 1997. MRI-defined vascular depression. Am. J. Psychiatry 154: 497-501.
48. deGroot, J.C., F.E. deLeeuw, M. Oudkerk, et al. 2000. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch. Gen. Psychiatry 57: 1071-1076.
49. Lyoo, I.K., H.K. Lee, J.H. Jung, et al. 2002. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr. Psychiatry 43: 361-368.
50. Lenze, E., D. Cross, D. McKeel, et al. 1999. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am. J. Psychiatry 156: 1602-1607.
51. Iosifescu, D.V., P.F. Renshaw, I.K. Lyoo, et al. 2006. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br. J. Psychiatry 188: 180-185.
52. Alexopoulos, G.S., B.S. Meyers, R.C. Young, et al. 1997. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 54: 915-922.
53. Simpson, S., R.C. Baldwin, A. Jackson & A.S. Burns . 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol. Med. 28: 1015-1026.
54. Iosifescu, D.V., P.F. Renshaw, D.D. Dougherty, et al. 2007. Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities. J. Nerv. Ment. Dis. 195: 175-178.
55. O'Brien, J., D. Ames, E. Chiu, I. Schweitzer, et al. 1998. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ 317: 982-984.
56. Sexton, C.E., C.E. Mackay, K.P. Ebmeier . 2009. A systematic review of diffusion tensor imaging studies in affective disorders. Biol. Psychiatry 66: 814-823.
57. Liao, Y., X. Huang, Q. Wu, et al. 2013. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J. Psychiatry Neurosci. 38: 49-56.
58. Alexopoulos, G.S., D.N. Kiosses, S.J. Choi, et al. 2002. Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am. J. Psychiatry 159: 1929-1932.
59. Taylor, W.D., J.R. MacFall, M.E. Payne, et al. 2004. Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am. J. Psychiatry 161: 1293-1296.
60. Bae, J.N., J.R. MacFall, K.R. Krishnan, et al. 2006. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol. Psychiatry 60: 1356-1363.
61. Cole, J., C.A. Chaddock, A.E. Farmer, et al. 2012. White matter abnormalities and illness severity in major depressive disorder. Br. J. Psychiatry 201: 33-39.
62. Carballedo, A., F. Amico, I. Ugwu, et al. 2012. Reduced FA in the uncinate fasciculus in patients with MD carrying the met-allele of the Val66Met BDNF genotype. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B: 537-548.
63. Cullen, K.R., B. Klimes-Dougan, R. Muetzel, et al. 2010. Altered white matter microstructure in adolescents with major depression: a preliminary study. J. Am. Acad. Child Adolesc. Psychiatry 49: 173-183.
64. Osoba, A., J. Hänggi, M. Li, et al. 2013. Disease severity is correlated to tract specific changes of fractional anisotropy in MD and CM thalamus-a DTI study in major depressive disorder. J. Affect. Disord. 149: 116-128.
65. Zou, K., W. Deng, T. Li, et al. 2010. Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study. Biol. Psychiatry 67: 186-188.
66. Price, J.L. & W.C. Drevets . 2010. Neurocircuitry of mood disorders. Neuropsychopharmacology 35: 192-216.
67. Abe, O., H. Takao, W. Gonoi, et al. 2010. Voxel-based analysis of the diffusion tensor. Neuroradiology 52: 699-710.
68. Kieseppa, T., M. Eerola, R. Mantyla, et al. 2010. Major depressive disorder and white matter abnormalities: a diffusion tensor imaging study with tract-based spatial statistics. J. Affect. Disord. 120: 240-244.
69. Korgaonkar, M.S., S.M. Grieve, S.H. Koslow, et al. 2010. Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging. Hum. Brain Mapp. 32: 2161-2171.
70. Choi, K.S., P.E. Holtzheimer, A.R. Franco, et al. 2014. Reconciling variable findings of white matter integrity in major depressive disorder. Neuropsychopharmacology 39: 1332-1339.
71. Kear-Colwell, J.J. 1972. A taxonomy of depressive phenomena and its relationships to the reactive-endogenous dichotomy. Br. J. Psychiatry 121: 665-671.
72. Quinn, C., A. Harris, & A.H. Kemp . 2012. The interdependence of subtype and severity: contributions of clinical and neuropsychological features to melancholia and non-melancholia in an outpatient sample. J. Int. Neuropsychol. Soc. 18: 361-369.
73. Teicher, M.H. & J.A. Samson . 2013. Childhood maltreatment and psychopathology: a case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am. J. Psychiatry 170: 1114-1133.
74. Malki, K., R. Keers, M.G. Tosto, et al. 2014. The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder. BMC Med. 12: 73.
75. Ionescu, D.F., M.J. Niciu, D.C. Mathews, et al. 2013. Neurobiology of anxious depression: a review. Depress Anxiety 30: 374-385.
76. Spashett, R., G. Fernie, I.C. Reid & I.M. Cameron . 2014. MADRS symptom subtypes in ECT-treated depressed patients: relationship to response and subsequent ECT. J. ECT 30: 227-231.
77. Flint, J. & K.S. Kendler . 2014. The genetics of major depression. Neuron 81: 484-503.
78. van Loo, H.M., T. Cai, M.J. Gruber, et al. 2014. Major depressive disorder subtypes to predict long-term course. Depress Anxiety 31: 765-777.
79. Bühler, J., 2014. Seemüller F2, Läge D3. The predictive power of subgroups: an empirical approach to identify depressive symptom patterns that predict response to treatment. J. Affect. Disord. 163: 81-87.
80. Shah, P.J., M.F. Glabus, G.M. Goodwin & K.P. Ebmeier . 2002. Chronic, treatment-resistant depression and right fronto-striatal atrophy. Br. J. Psychiatry 180: 434-440.
81. Li, C.T., C.P. Lin, K.H. Chou, et al. 2010. Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage 50: 347-356.
82. Zhou, Y., L.D. Qin, J. Chen, et al. 2011. Brain microstructural abnormalities revealed by diffusion tensor images in patients with treatment-resistant depression compared with major depressive disorder before treatment. Eur. J. Radiol. 80: 450-454.
83. Guo, W.B., F. Liu, J.D. Chen, et al. 2012. Altered white matter integrity of forebrain in treatment-resistant depression: a diffusion tensor imaging study with tract-based spatial statistics. Prog. Neuropsychopharmacol. Biol. Psychiatry 38: 201-206.
84. Peng, H.J., H.R. Zheng, Y.P. Ning, et al. 2013. Abnormalities of cortical-limbic-cerebellar white matter networks may contribute to treatment-resistant depression: a diffusion tensor imaging study. BMC Psychiatry 13: 72.
85. Hoogenboom, W.S., R.H. Perlis, J.W. Smoller, et al. 2014. Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data. World J. Biol. Psychiatry 15: 122-134.
86. de Diego-Adeliño, J., P. Pires, B. Gómez-Ansón, et al. 2014. Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychol. Med 44: 1171-1182.
87. Taylor, W.D., M. Kuchibhatla, M.E. Payne, et al. 2008. Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS One 3: e3267.
88. Gutman, D.A., P.E. Holtzheimer, T.E. Behrens, et al. 2009. A tractography analysis of two deep brain stimulation white matter targets for depression. Biol. Psychiatry 65: 276-282.
89. Höflich, A., M. Savli, E. Comasco, et al. 2013. Neuropsychiatric deep brain stimulation for translational neuroimaging. Neuroimage 9: 30-41.
90. Peng, H., H. Zheng, L. Li, et al. 2012. High-frequency rTMS treatment increases white matter FA in the left middle frontal gyrus in young patients with treatment-resistant depression. J. Affect. Disord. 136: 249-257.
91. Korgaonkar, M.S., L.M. Williams, Y.J. Song, et al. 2014. Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder. Br. J. Psychiatry 205: 321-328.
92. Diener, C., C. Kuehner, W. Brusniak, et al. 2012. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage 61: 677-685.
93. Hamilton, J.P., A. Etkin, D.J. Furman, et al. 2012. Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data. Am. J. Psychiatry 169: 693-703.
94. Kerestes, R., C.G. Davey, K. Stephanou, et al. 2013. Functional brain imaging studies of youth depression: a systematic review. Neuroimage Clin. 4: 209-231.
95. Treadway, M.T. & D.A. Pizzagalli . 2014. Imaging the pathophysiology of major depressive disorder-from localist models to circuit-based analysis. Biol. Mood Anxiety Disord. 4: 5.
96. Drevets, W.C., T.O. Videen, J.L. Price, et al. 1992. A functional anatomical study of unipolar depression. J. Neurosci. 12: 3628-3641.
97. Sheline, Y.I., D.M. Barch, J.M. Donnelly, et al. 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50: 651-658.
98. Siegle, G.J., S.R. Steinhauer, M.E. Thase, et al. 2002. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51: 693-707.
99. Phillips, M.L., W.C. Drevets, S.L. Rauch & R. Lane . 2003. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry 54: 515-528.
100. Victor, T.A., M.L. Furey, S.J. Fromm, et al. 2010. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch. Gen. Psychiatry 67: 1128-1138.
101. Fossati, P., S.J. Hevenor, S.J. Graham, et al. 2003. In search of the emotional self: an fMRI study using positive and negative emotional words. Am. J. Psychiatry 160: 1938-1945.
102. Fu, C.H., S.C. Williams, A.J. Cleare, et al. 2004. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 61: 877-889.
103. Ochsner, K.N., R.D. Ray, J.C. Cooper, et al. 2004. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 23: 483-499.
104. Ochsner, K.N., R.R. Ray, B. Hughes, et al. 2009. Bottom-up and top-down processes in emotion generation: common and distinct neural mechanisms. Psychol. Sci. 20: 1322-1331.
105. Johnstone, T., C.M. vanReekum, H.L. Urry, et al. 2007. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J. Neurosci. 27: 8877-8884.
106. Townsend, J. & L.L. Altshuler . 2012. Emotion processing and regulation in bipolar disorder: a review. Bipolar Disord. 14: 326-339.
107. Mochcovitch, M.D., R.C. da Rocha Freire, R.F. Garcia & A.E. Nardi . 2014. A systematic review of fMRI studies in generalized anxiety disorder: evaluating its neural and cognitive basis. J. Affect. Disord. 167C: 336-342.
108. Etkin, A. & A.F. Schatzberg . 2011. Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. Am. J. Psychiatry 168: 968-978.
109. Etkin, A. & T.D. Wager . 2007. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 164: 1476-1488.
110. Hazlett, E.A., J. Zhang, A.S. New, et al. 2012. Potentiated amygdala response to repeated emotional pictures in borderline personality disorder. Biol. Psychiatry 72: 448-456.
111. Malhi, G.S., M. Tanious, K. Fritz, et al. 2013. Differential engagement of the fronto-limbic network during emotion processing distinguishes bipolar and borderline personality disorder. Mol. Psychiatry 18: 1247-1248.
112. Mitterschiffthaler, M.T., V. Kumari, G.S. Malhi, et al. 2003. Neural response to pleasant stimuli in anhedonia: an fMRI study. Neuroreport 14: 177-182.
113. Keedwell, P.A., C. Andrew, S.C. Williams, et al. 2005. A double dissociation of ventromedial prefrontal cortical responses to sad and happy stimuli in depressed and healthy individuals. Biol. Psychiatry 58: 495-503.
114. Pizzagalli, D.A., A.J. Holmes, D.G. Dillon, et al. 2009. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am. J. Psychiatry 166: 702-710.
115. Nejad, A.B., P. Fossati & C. Lemogne . 2013. Self-referential processing, rumination, and cortical midline structures in major depression. Front. Hum. Neurosci. 7: 666.
116. Kross, E., M. Davidson, J. Weber & K. Ochsner . 2009. Coping with emotions past: the neural bases of regulating affect associated with negative autobiographical memories. Biol. Psychiatry 65: 361-366.
117. Lemogne, C., G. le Bastard, H. Mayberg, et al. 2009. In search of the depressive self: extended medial prefrontal network during self-referential processing in major depression. Soc. Cogn. Affect. Neurosci. 4: 305-312.
118. Yoshimura, S., Y. Okamoto, K. Onoda, et al. 2010. Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity. J. Affect. Disord. 122: 76-85.
119. Grimm, S., J. Ernst, P. Boesiger, et al. 2009. Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures. Hum. Brain Mapp. 30: 2617-2627.
120. Sheline, Y.I., D.M. Barch, J.L. Price, et al. 2009. The default mode network and self-referential processes in depression. Proc. Natl. Acad. Sci. U.S.A. 106: 1942-1947.
121. Brody, A.L., S. Saxena, D.H. Silverman, et al. 1999. Brain metabolic changes in major depressive disorder from pre- to posttreatment with paroxetine. Psychiatry Res. 91: 127-139.
122. Little, J.T., T.A. Ketter, T.A. Kimbrell, et al. 2005. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol. Psychiatry 57: 220-228.
123. Miller, J.M., N. Schneck, G.J. Siegle, et al. 2013. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study. Psychiatry Res. 214: 296-305.
124. Miller, J.M., N. Schneck, G.J. Siegle, et al. 2014. Corrigendum to "fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study" [Psychiatry Res.: Neuroimaging 214 (2013) 296-305] Psychiatry Res. 222: 173-175.
125. Davidson, R.J., W. Irwin, M.J. Anderle & N.H. Kalin . 2003. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am. J. Psychiatry 160: 64-75.
126. Keedwell, P.A., D. Drapier, S. Surguladze, et al. 2010. Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. J. Affect. Disord. 120: 120-125.
127. Keedwell, P., D. Drapier, S. Surguladze, et al. 2009. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J. Psychopharmacol. 23: 775-788.
128. Mayberg, H.S., S.K. Brannan, R.K. Mahurin, et al. 1997. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8: 1057-1061.
129. Pizzagalli, D.A. 2011. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36: 183-206.
130. Salvadore, G., B.R. Cornwell, V. Colon-Rosario, et al. 2009. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol. Psychiatry 65: 289-295.
131. Salvadore, G., B.R. Cornwell, F. Sambataro, et al. 2010. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology 35: 1415-1422.
132. Siegle, G.J., C.S. Carter & M.E. Thase . 2006. Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am. J. Psychiatry 163: 735-738.
133. Siegle, G.J., W.K. Thompson, A. Collier, et al. 2012. Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch. Gen. Psychiatry 69: 913-924.
134. Milak, M.S., R.V. Parsey, L. Lee, et al. 2009. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res. 173: 63-70.
135. Konarski, J.Z., S.H. Kennedy, Z.V. Segal, et al. 2009. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J. Psychiatry Neurosci. 34: 175-180.
136. DeRubeis, R.J., G.J. Siegle & S.D. Hollon . 2008. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 9: 788-796.
137. Roiser, J.P., R. Elliott & B.J. Sahakian . 2012. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37: 117-136.
138. Sanacora, G., G. Treccani & M. Popoli . 2012. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62: 63-77.
139. Yildiz-Yesiloglu, A. & D.P. Ankerst . 2006. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res. 147: 1-25.
140. Gabbay, V., D.A. Hess, S. Liu, et al. 2007. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am. J. Psychiatry 164: 1881-1889.
141. Kondo, D.G., T.L. Hellem, Y.H. Sung, et al. 2011. Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder. Depress Res. Treat. 2011: 650450.
142. Caverzasi, E., A. Pichiecchio, G.U. Poloni, et al. 2012. Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct. Neurol. 27: 13-22.
143. Obergriesser, T., G. Ende, D.F. Braus & F.A. Henn . 2003. Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy. J. Clin. Psychiatry 64: 775-780.
144. Block, W., F. Träber, O. vonWiddern, et al. 2009. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int. J. Neuropsychopharmacol. 12: 415-422.
145. Sözeri-Varma, G., N. Kalkan-Oğuzhanoglu, M. Efe, et al. 2013. Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression. Neuropsychiatr. Dis. Treat. 9: 1053-1059.
146. Sonawalla, S.B., P.F. Renshaw, C.M. Moore, et al. 1999. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. Am. J. Psychiatry 156: 1638-1640.
147. Gonul, A.S., O. Kitis, E. Ozan, et al. 2006. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 30: 120-125.
148. Ende, G., D.F. Braus, S. Walter, et al. 2000. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch. Gen. Psychiatry 57: 937-943.
149. Sanacora, G., G.F. Mason, D.L. Rothman, et al. 1999. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56: 1043-1047.
150. Sanacora, G., R. Gueorguieva, C.N. Epperson, et al. 2004. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 61: 705-713.
151. Sanacora, G., G.F. Mason, D.L. Rothman & J.H. Krystal . 2002. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry 159: 663-665.
152. Sanacora, G., G.F. Mason, D.L. Rothman, et al. 2003. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry 160: 577-579.
153. Gabbay, V., X. Mao, R.G. Klein, et al. 2012. Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch. Gen. Psychiatry 69: 139-149.
154. Hasler, G., A. Neumeister, J.W. vander Veen, et al. 2005. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol. Psychiatry 58: 969-973.
155. Yüksel, C. & D. Öngür . 2010. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol. Psychiatry 68: 785-794.
156. Luykx, J.J., K.G. Laban, M.P. vanden Heuvel, et al. 2012. Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neurosci. Biobehav. Rev. 36: 198-205.
157. Berman, R.M., A. Cappiello, A. Anand, et al. 2000. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47: 351-354.
158. Murrough, J.W., D.V. Iosifescu, L.C. Chang, et al. 2013. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 170: 1134-1142.
159. McGirr, A., M.T. Berlim, D.J. Bond, et al. 2015. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med. 45: 693-704.
160. Stone, J.M., C. Dietrich, R. Edden, et al. 2012. Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol. Psychiatry 17: 664-665.
161. Dantzer, R., J.C. O'Connor, G.G. Freund, et al. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9: 46-56.
162. Dantzer, R., J.C. O'Connor, M.A. Lawson & K.W. Kelley . 2011. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36: 426-436.
163. Lopresti, A.L., G.L. Maker, S.D. Hood & P.D. Drummond . 2014. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog. Neuropsychopharmacol. Biol. Psychiatry 48: 102-111.
164. Berk, M., F. Ng, O. Dean, et al. 2008. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol. Sci. 29: 346-351.
165. Berk, M., O.M. Dean, S.M. Cotton, et al. 2014. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. J. Clin. Psychiatry 75: 628-636.
166. Kaiser, L.G., M. Marjańska, G.B. Matson, et al. 2010. (1)H MRS detection of glycine residue of reduced glutathione in vivo. J. Magn. Reson. 202: 259-266.
167. Shungu, D.C., N. Weiduschat, J.W. Murrough, et al. 2012. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 25: 1073-1087.
168. Godlewska, B.R., J. Near & P.J. Cowen . 2015. Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology (Berl). 232: 501-507.
169. Lapidus, K.A., V. Gabbay, X. Mao, et al. 2014. In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder. Neurosci. Lett. 569: 74-79.
170. Volz, H.P., et al. 1998. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 248: 289-295.
171. Moore, C.M., et al., 1997. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am. J. Psychiatry 154: 116-118.
172. Renshaw, P.F., et al. 2001. Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. Am. J. Psychiatry 158: 2048-2055.
173. Iosifescu, D.V., et al. 2008. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol. Psychiatry 63: 1127-1134.
174. Frodl, T., C. Schüle, G. Schmitt, et al. 2007. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 64: 410-416.
175. Forde, N.J., L. Ronan, J. Suckling, et al. 2014. Structural neuroimaging correlates of allelic variation of the BDNF val66met polymorphism. Neuroimage 90: 280-289.
176. Hayashi, K., R. Yoshimura, S. Kakeda, et al. 2014. COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study. Neuropsychiatr. Dis. Treat. 10: 1183-1190.
177. Seok, J.H., S. Choi, H.K. Lim, et al. 2013. Effect of the COMT val158met polymorphism on white matter connectivity in patients with major depressive disorder. Neurosci. Lett. 545: 35-39.